Sinofn Health
Sinofn Health
In the current global nutraceutical landscape, the demand for transparency, efficacy, and rapid innovation has never been higher. As a seasoned leader in the OEM/ODM manufacturing sector, SINOFN bridges the gap between scientific research and market-ready products. We move beyond simple "contract manufacturing" to provide a holistic ecosystem for brand owners.
We are witnessing a shift where "Made in China" is synonymous with "Smart Manufacturing." At SINOFN, our Factory 4.0 initiative leverages IoT-enabled production lines, real-time data monitoring, and automated quality control. This digital transformation ensures that every batch—from raw material intake to final packaging—is tracked with granular precision, significantly reducing human error and enhancing production efficiency. This isn't just about speed; it's about the reliability that global enterprise buyers demand.
The future of health supplements lies in Personalized Nutrition and Bioavailability. Our R&D team, backed by the Chinese Academy of Sciences, is currently focusing on:
By partnering with SINOFN, you are not just hiring a factory; you are engaging an innovation partner that anticipates market trends rather than merely following them.
Founded in 2012, backed by the Chinese Academy of Sciences, we transformed from clinical research to large-scale nutraceutical manufacturing.
Mrs. GuoHong Liu, our founder, pioneered affordable PKU foods, instilling a "Profit with Purpose" culture in every product we manufacture.
Led by Dr. Zhang Ying (CAS) and Dr. Tan Shengjie (Peking University), our team treats every formulation as a clinical development project.
Production Facility
RMB Capital
Technical Patents
Registered Trademarks
A: We operate under stringent GMP, ISO 22000, and HACCP standards. Our team works closely with international regulatory bodies to ensure that your products meet local labeling and ingredient requirements, whether you are targeting the EU, North America, or Asia.
A: Startups benefit from our agility. Our digital production lines allow for smaller, pilot-scale testing runs before scaling up, minimizing your capital risk while maintaining high-quality output.
A: Absolutely. Our R&D center, led by experts from the Chinese Academy of Sciences, specializes in translating your conceptual product ideas into stable, effective, and bioavailable formulas.
